Danaher Corporation $DHR Shares Sold by Securian Asset Management Inc.

Securian Asset Management Inc. decreased its position in Danaher Corporation (NYSE:DHRFree Report) by 46.7% during the 4th quarter, Holdings Channel reports. The fund owned 17,094 shares of the conglomerate’s stock after selling 14,985 shares during the quarter. Securian Asset Management Inc.’s holdings in Danaher were worth $3,913,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at approximately $26,000. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher in the third quarter valued at approximately $27,000. Finally, Financial Life Planners purchased a new position in Danaher in the third quarter valued at approximately $32,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 10.80% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $170.98 on Monday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market cap of $121.01 billion, a PE ratio of 33.07, a price-to-earnings-growth ratio of 2.29 and a beta of 0.81. The company’s 50 day simple moving average is $191.25 and its 200-day simple moving average is $212.54. Danaher Corporation has a 12-month low of $170.74 and a 12-month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm posted $1.88 earnings per share. As a group, equities analysts predict that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analyst Ratings Changes

Several equities analysts have commented on DHR shares. TD Cowen dropped their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Morgan Stanley dropped their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Finally, Wells Fargo & Company dropped their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Eighteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $240.70.

Check Out Our Latest Stock Analysis on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.